Exascale Labs Holdings Inc. filed a Form 8-K at 14:23 UTC on Monday, 9 November 2026. The Framework Agreement does not obligate the Company to purchase any minimum quantity; the Company’s purchase and payment obli
Form 8-K is the current report that U.S. public companies file with the SEC to disclose significant events between their regular reports. This filing reports Item 1.01 (Entry into a Material Definitive Agreement) and Item 9.01 (Financial Statements and Exhibits).
Source: U.S. Securities and Exchange Commission (EDGAR) filing